drugset

Drugs / HTK

Follow last change Dec 2025 re-read 3 minutes ago

HTK

also known as Histidine, Tryptophan and Ketoglutarate solution

Developed for: myocardial ischemia
Investigated by: Ahmed Ismail Abdelsabour · Amr Ibrahim Abdelaal · Assiut University · Ibrahim Mohamed Imbaby · Mahmoud Mohamed Atef Sallam · Mohamed, Ahmed Abdelhay Mohamed
+1 more
· Ramy Mustafa Abdelgawad Mohamed

Trials 1

today NCT06414330 · Ph 3

20252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT06414330	Jun 2024 → Nov 2025	myocardial ischemia	Assiut University	Completed	No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	HTK	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06414330 ↗
Known as	Histidine, Tryptophan and Ketoglutarate solution	“Group (C ) will receive HTK (Histidine, Tryptophan and Ketoglutarate solution)” NCT06414330 ↗
Route	Other	“cardioplegia will be injected between the aortic valve and aortic cross clamp” NCT06414330 ↗